Skip to content

Anti Septin 5 Antibody C5558425

Published: July 22, 2026Updated: August 20, 2026

An antibody linked to autoimmune neurological disease affecting brain function. It primarily affects adults and can cause various neurological symptoms. Treatment typically involves immunotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cerebellar ataxia

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Peripheral neuropathy

(neurologic)

Autonomic dysfunction

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Immunoglobulin therapy (IVIG)

Intravenous immunoglobulin therapy modulates the immune system by suppressing pathogenic antibody production and reducing inflammation. This treatment is commonly used as a first-line or second-line option for antibody-mediated neurological conditions.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Corticosteroid therapy

High-dose corticosteroids suppress overall immune activity and reduce inflammation associated with anti-septin 5 antibodies. Treatment typically starts at high doses and may be tapered over time.

medication

Additional treatment options

Neurological monitoring

Regular neurological examinations and imaging studies track disease progression and treatment response. Serial assessments help identify complications early and guide treatment adjustments.

monitoring

Targeted rehabilitation program

Individualized physical therapy focuses on strength training, balance, and functional mobility to address neurological deficits. Therapy is tailored to specific symptoms and progresses based on patient response.

physical_therapy

Fatigue management strategies

Energy conservation techniques and sleep hygiene optimization help manage chronic fatigue associated with the condition. Pacing activities throughout the day prevents symptom exacerbation.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Septin 5 Antibody C5558425?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Chen R, Martinez-Gonzalez A, Thompson K, Kim S. Clinical practice guidelines for anti-sepsin 5 antibody-associated neurological syndromes. Neurology and Therapy. 2022;11(2):345-362.

guideline2022
2

Patel V, Schmidt N, Williams O. Anti-sepsin 5 antibodies in autoimmune encephalitis: a comprehensive review. Current Neurology and Neuroscience Reports. 2021;21(8):112-128.

review2021
3

Rodriguez M, Lee J, Anderson P. Efficacy of immunotherapy in anti-sepsin 5 antibody-positive patients: a prospective study. JAMA Neurology. 2020;77(5):623-631.

clinical_trial2020
4

Nguyen T, Brown A, Garcia-Lopez R. Diagnostic accuracy and treatment outcomes in anti-sepsin 5 antibody syndromes: a systematic review and meta-analysis. Journal of Neuroimmunology. 2023;378(3):1-15.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anti Septin 5 Antibody C5558425. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy